Kaken Pharmaceutical Co Ltd 4521
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- ¥3,785.00
- Day Range
- ¥3,790.00–3,835.00
- 52-Week Range
- ¥3,540.00–4,445.00
- Bid/Ask
- ¥3,815.00 / ¥3,825.00
- Shares Outstanding
- 37.87M
- Market Cap
- ¥144.47B
- Volume/Avg
- 67,500 / 125,533
Key Statistics
- Price/Earnings (Normalized)
- 73.14
- Price/Sales
- 1.87
- Dividend Yield (Trailing)
- 5.02%
- Dividend Yield (Forward)
- 5.02%
- Dividend Payment Schedule
- Jun, Nov
- Total Yield
- 6.65%
Company Profile
Kaken Pharmaceutical Co Ltd is a specialty and generic drug manufacturing company. The company organizes its segments between pharmaceutical and real estate activities. The pharmaceutical segment consists of pharmaceutical drugs, medical devices, and agrochemicals. In the real estate segment, the majority of revenue is generated through commercial facility rental fees. Sales in Japan constitute more than 90% of revenue. Kaken considers merger and acquisition investment to be a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Value
- Total Number of Employees
- 1,298
- Website
- https://www.kaken.co.jp
Valuation
|
Metric
|
4521
|
|---|---|
Price/Earnings (Normalized) | 73.14 |
Price/Book Value | 0.97 |
Price/Sales | 1.87 |
Price/Cash Flow | — |
Price/Earnings
4521
Financial Strength
|
Metric
|
4521
|
|---|---|
Quick Ratio | 3.53 |
Current Ratio | 4.52 |
Interest Coverage | 46.29 |
Quick Ratio
4521
Profitability
|
Metric
|
4521
|
|---|---|
Return on Assets (Normalized) | — |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | — |
Return on Assets
4521
Drug Manufacturers - Specialty & Generic Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Merck KGaA ADR
MKKGY
| LOCK|NH$?^s& | LOCK|XVww^ | $69B | |||
| Teva Pharmaceutical Industries Ltd
TEVA
| LOCK|n!WnqpL | LOCK|YV?z | $49B | |||
| Haleon PLC ADR
HLN
| LOCK|!f$&Yk | LOCK|DzT | $42B | |||
| Zoetis Inc Class A
ZTS
| LOCK|y@KY@c$B | LOCK|y@ | $31B | |||
| Viatris Inc
VTRS
| LOCK|&&NL#< | LOCK|mb& | $20B | |||
| Elanco Animal Health Inc
ELAN
| LOCK|>X | LOCK|<zb | $11B | |||
| Dr Reddy's Laboratories Ltd ADR
RDY
| LOCK|Zb!V#Y | LOCK|HP@ | $11B | |||
| Hims & Hers Health Inc Ordinary Shares - Class A
HIMS
| LOCK|z&$x^HL | LOCK|$M | $6B | |||
| Prestige Consumer Healthcare Inc
PBH
| LOCK|?&@$&#b | LOCK|Dt$^ | $2B | |||
| Perrigo Co PLC
PRGO
| LOCK|gF<&Px | LOCK|VKf | $2B |
United States